ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Hexagon Nutrition Investor Presentation: Key Takeaways

Hexagon Nutrition reported Q1 FY27 revenue of ₹1,043 Mn with 11.3% EBITDA margin. The firm focuses on specialized clinical and wellness nutrition brands like Pentasure and Pediagold.

Highlights
Revenue growth43.16% YoY
MarginsEBITDA margin 11.31% vs 13.81% YoY.
Demand visibilityRising NCDs and ageing population fueling clinical nutrition demand.

Growth

Revenue grew 43.16% YoY to ₹1,043.06 Mn; PAT increased 25.07% YoY to ₹80.73 Mn.

Outlook

Targeting 15%+ medium-term EBITDA margins through improved B2C mix (>35% of revenue) and operational leverage.

Risks

Challenges include regional nutritional gaps, consumer misinformation, and high dependence on domestic markets for raw materials.

Source

Investor Presentation filed with NSE, NSE: HEXAGON. Summary written with AI assistance from the document.

Read the document ↗

Hexagon Nutrition Ltd: key numbers

Share price
₹59.99
Market cap
₹737.4 Cr
Revenue (annual)
₹382.6 Cr
Net profit (annual)
₹37.94 Cr
P/E (TTM)
18.6×Sector 41.3×
Promoter holding
64.36%+0.07% QoQ
FII holding
0.29%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Hexagon Nutrition Ltd

All →